000 | 01506 a2200445 4500 | ||
---|---|---|---|
005 | 20250514072752.0 | ||
264 | 0 | _c20030722 | |
008 | 200307s 0 0 eng d | ||
022 | _a1565-1088 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLidar, Merav | |
245 | 0 | 0 |
_aProtracted Mycobacterium kansasii carpal tunnel syndrome and tenosynovitis. _h[electronic resource] |
260 |
_bThe Israel Medical Association journal : IMAJ _cJun 2003 |
||
300 |
_a453-4 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAnti-Bacterial Agents |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
650 | 0 | 4 |
_aAsthma _xcomplications |
650 | 0 | 4 |
_aCarpal Tunnel Syndrome _xdiagnosis |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aDebridement |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunocompromised Host |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMycobacterium Infections, Nontuberculous _xdiagnosis |
650 | 0 | 4 | _aMycobacterium kansasii |
650 | 0 | 4 |
_aPrednisone _xadverse effects |
650 | 0 | 4 | _aReoperation |
650 | 0 | 4 |
_aTenosynovitis _xdiagnosis |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aElkayam, Ori | |
700 | 1 | _aGoodwin, David | |
700 | 1 | _aYaron, Michael | |
700 | 1 | _aCaspi, Dan | |
773 | 0 |
_tThe Israel Medical Association journal : IMAJ _gvol. 5 _gno. 6 _gp. 453-4 |
|
999 |
_c12623033 _d12623033 |